{
  "PARK7 M26I": {
    "variant_string_id": "PARK7 M26I",
    "steps": [
      {
        "step": "Step 1: Define the disease mechanism",
        "description": "The paper establishes that PARK7/DJ-1 mutations are linked to autosomal-recessive early-onset PD. The study demonstrates that these mutations disrupt TTRAP interaction and trigger apoptosis via JNK/p38-MAPK pathways, directly linking them to disease mechanisms.",
        "judgment": "Yes"
      },
      {
        "step": "Step 2: Evaluate assay applicability",
        "description": "Yeast two-hybrid screening was used to assess protein interactions (TRAF/TTRAP) relevant to PD pathogenesis. This assay aligns with the disease mechanism of disrupted cellular protection.",
        "judgment": "Yes"
      },
      {
        "step": "Step 3a: Basic controls and replicates",
        "description": "Wild-type DJ-1 and mutant variants (M26I/L166P) were compared. The study explicitly contrasts mutant and wild-type binding, fulfilling the requirement for normal/abnormal controls. However, the text does not mention statistical replicates (e.g., n=3).",
        "judgment": "Yes"
      },
      {
        "step": "Step 3c: Variant controls",
        "description": "No additional pathogenic/benign variant controls were used in the assay. The analysis focused solely on the tested mutants and wild-type.",
        "judgment": "No"
      },
      {
        "step": "Step 4b: No OddsPath calculation",
        "description": "The paper reports qualitative findings (e.g., 'bind more strongly than wild-type') but lacks statistical tests, p-values, or OddsPath calculations. Only two variants (M26I/L166P) were tested, with wild-type as a control.",
        "judgment": "10 or less controls",
        "strength": "Max PS3_supporting"
      }
    ],
    "final_strength": {
      "category": "PS3",
      "sub_category": "supporting",
      "description": "The variant disrupts TTRAP interaction and triggers apoptosis, aligning with pathogenic mechanisms. However, limited statistical rigor and controls reduce strength to 'supporting'."
    }
  },
  "PARK7 L166P": {
    "variant_string_id": "PARK7 L166P",
    "steps": [
      {
        "step": "Step 1: Define the disease mechanism",
        "description": "As with M26I, the study confirms that L166P mutations impair TTRAP interaction and induce apoptosis, directly contributing to PD pathogenesis.",
        "judgment": "Yes"
      },
      {
        "step": "Step 2: Evaluate assay applicability",
        "description": "The yeast two-hybrid assay remains relevant for assessing TTRAP interaction and its role in apoptosis, consistent with the disease mechanism.",
        "judgment": "Yes"
      },
      {
        "step": "Step 3a: Basic controls and replicates",
        "description": "Wild-type DJ-1 and mutant variants (L166P) were compared, fulfilling the normal/abnormal control requirement. Replicates are not explicitly mentioned.",
        "judgment": "Yes"
      },
      {
        "step": "Step 3c: Variant controls",
        "description": "No additional pathogenic/benign variant controls were used in the assay. The analysis focused solely on the tested mutants and wild-type.",
        "judgment": "No"
      },
      {
        "step": "Step 4b: No OddsPath calculation",
        "description": "The study lacks statistical tests, p-values, or OddsPath calculations. Only two variants (L166P) were tested, with wild-type as a control.",
        "judgment": "10 or less controls",
        "strength": "Max PS3_supporting"
      }
    ],
    "final_strength": {
      "category": "PS3",
      "sub_category": "supporting",
      "description": "The variant disrupts TTRAP interaction and triggers apoptosis, aligning with pathogenic mechanisms. However, limited statistical rigor and controls reduce strength to 'supporting'."
    }
  }
}